Skip to main content



Ann Lamont (“Annie”) is a Managing Partner of Oak Investment Partners.  Annie joined Oak in 1982 and served as General Partner from 1986 to 2006.  She currently leads the healthcare and payment services teams at Oak.

Annie currently serves on the Boards of Acculynk, Benefitfocus, Castlight Health, Independent Living Systems, NetSpend, PharMEDium Healthcare, Precision Health Holdings, Radisphere National Radiology Group and xG Health Solutions.  Prior investments include athenahealth, American Esoteric Laboratories (acquired by Sonic Healthcare Limited), Argus Information & Advisory Services (acquired by Verisk Analytics), CareMedic Systems (acquired by Ingenix), CLARiENT (acquired by GE Healthcare), Harbor Payments (acquired by American Express), Health Dialog (acquired by British United Provident Association), Odyssey Healthcare, Oak Tree/Oxford, PayFlex (acquired by Aetna), Point Carbon (acquired by Thomson Reuters), Psychiatric Solutions, TxVia (acquired by Google) and United BioSource (acquired by Medco Health Solutions). Earlier in Annie's venture career, she developed a number of successful biopharmaceutical investments (Cephalon, ViroPharma, Esperion).

Prior to joining Oak, Annie was a research associate with Hambrecht & Quist.  Annie recently served on the Stanford University Board of Trustees. She has also served on the Executive Board of the National Venture Capital Association.  Annie graduated from Stanford University with a BA in Political Science.